Sandbox:khurram: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 35: | Line 35: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Platelet count | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Platelet count | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PT | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PT | ||
! | !aPTT | ||
!Peripheral blood smear | !Peripheral blood smear | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bleeding time | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bleeding time | ||
Line 50: | Line 50: | ||
| | | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 153: | Line 153: | ||
| | | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Decreased | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Increased | ||
| | |Increased | ||
| | | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Increased | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 164: | Line 164: | ||
| style="background: #F5F5F5; padding: 5px;" |Ristocetin cofactor assay | | style="background: #F5F5F5; padding: 5px;" |Ristocetin cofactor assay | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Elevated fibrin degradation products | |||
* Elevated D-dimer levels | |||
|- | |- | ||
|Antiphospholipid antibody syndrome | |Antiphospholipid antibody syndrome |
Revision as of 18:47, 23 August 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Differentiating [disease name] from other diseases on the basis of [symptom 1], [symptom 2], and [symptom 3]
On the basis [symptom 1], [symptom 2], and [symptom 3], [disease name] must be differentiated from [disease 1], [disease 2], [disease 3], [disease 4], [disease 5], and [disease 6].
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | |||||||||||||||||
Lab Findings | Imaging | Histopathology | ||||||||||||||||
Symptoms of DVT | Symptoms of Pulmonary Embolism | Symptoms of Myocardial Infarction | Tenderness in extremities | Edema in extremities | Warmth in extremities | Skin necrosis | Platelet count | PT | aPTT | Peripheral blood smear | Bleeding time | Doppler ultrasound | Chest CT scan | Head CT with contrast | ||||
Antithrombin deficiency | - | - | - | - | - |
| ||||||||||||
Factor V Leiden mutation | ||||||||||||||||||
Protein C deficiency | ||||||||||||||||||
Protein S deficiency | ||||||||||||||||||
Prothrombin gene mutation | ||||||||||||||||||
DIC | Decreased | Increased | Increased | Increased | Ristocetin cofactor assay |
| ||||||||||||
Antiphospholipid antibody syndrome | ||||||||||||||||||
Heparin induced thrombocytopenia (HIT) |